Inclisiran plus statins for fragile heart plaque
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 80 years old
- Have at least one vulnerable (high-risk) plaque in a heart artery confirmed by special imaging
- Been on a statin for at least 4 weeks but still have high LDL (≥70 mg/dL or 1.8 mmol/L)
- No heart attack in the last 30 days
- No serious kidney, liver, or heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
This study tests whether a new injectable cholesterol-lowering drug (called a PCSK9 inhibitor) can help prevent further heart problems by making plaque in your arteries more stable and less likely to cause blocked vessels. It is for people who recently had a heart attack or unstable angina and already received a stent in the blocked artery.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
This study tests whether a twice-yearly injection called inclisiran can prevent heart attacks, strokes, or leg complications in people who recently had a procedure to open a blocked artery. You may be eligible if you had a heart or leg artery procedure within the last two weeks.
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
This trial tests a new version of inclisiran, a cholesterol-lowering medicine, to see if it is safe and works well. The study compares it to the current version. You may qualify if you have moderately high cholesterol but have never taken cholesterol medications.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.